Furosemide‑induced Eradication of Myeloblasts Via the Inhibition of Tumor Necrosis Factor‑α Expression in a Patient with Acute Biphenotypic Leukemia: A Case Report

Overview

Journal Oncol Lett

Specialty Oncology

Date 2024 Oct 14

PMID 39397800

Authors

Yu-Wei Chang

Wan-Ru Chao

Yen-Ting Lai

Frank Sheng Fan

Affiliations

Soon will be listed here.

Abstract

The present study reports the potential of furosemide therapeutic activity in acute myeloid leukemia. A 26-year-old man with acute biphenotypic leukemia was treated with furosemide for suspected pulmonary edema, which was later deemed to be an infiltration of leukemia cells. Notably, the myeloblast population was rapidly eliminated during furosemide therapy. Bone marrow specimens biopsied at different time points were used for immunohistochemical analysis of the expression levels of tumor necrosis factor-α (TNF-α) and its two receptors, TNF-α receptors 1 and 2. The expression of TNF-α and its receptors in the bone marrow was markedly suppressed by furosemide, along with the elimination of the myeloblasts. Thus, it was hypothesized that the growth of myeloblasts in the patient depended on autocrine and/or paracrine TNF-α stimulation, whereas furosemide disrupted this positive feedback loop. Therefore, furosemide is suggested as an effective therapeutic agent for acute myeloid leukemia, at least as an adjunct to standard chemotherapy and gene-targeted therapy.

References

Dong Q, Ling C, Chen X, Zhao L . Inhibition of tumor necrosis factor-α enhances apoptosis induced by nuclear factor-κB inhibition in leukemia cells. Oncol Lett. 2016; 10(6):3793-3798. PMC: 4665719. DOI: 10.3892/ol.2015.3786. View

Kagoya Y, Yoshimi A, Kataoka K, Nakagawa M, Kumano K, Arai S . Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity. J Clin Invest. 2014; 124(2):528-42. PMC: 3904603. DOI: 10.1172/JCI68101. View

Tuttolomondo A, Pinto A, Di Raimondo D, Corrao S, Di Sciacca R, Scaglione R . Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading. Nutr Metab Cardiovasc Dis. 2010; 21(5):372-9. DOI: 10.1016/j.numecd.2009.10.014. View

Zhou X, Li Z, Zhou J . Tumor necrosis factor α in the onset and progression of leukemia. Exp Hematol. 2016; 45:17-26. DOI: 10.1016/j.exphem.2016.10.005. View

Zhou X, Zhou S, Li B, Li Q, Gao L, Li D . Transmembrane TNF-α preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy. Blood. 2015; 126(12):1433-42. DOI: 10.1182/blood-2015-01-624833. View

Weinberg O, Arber D . How I Diagnose Acute Leukemia of Ambiguous Lineage. Am J Clin Pathol. 2022; 158(1):27-34. DOI: 10.1093/ajcp/aqac070. View

Tian T, Wang M, Ma D . TNF-α, a good or bad factor in hematological diseases?. Stem Cell Investig. 2016; 1:12. PMC: 4923506. DOI: 10.3978/j.issn.2306-9759.2014.04.02. View

Balkwill F . Tumour necrosis factor and cancer. Nat Rev Cancer. 2009; 9(5):361-71. DOI: 10.1038/nrc2628. View

Yuengsrigul A, Chin T, Nussbaum E . Immunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cells. Ann Allergy Asthma Immunol. 2000; 83(6 Pt 1):559-66. DOI: 10.1016/S1081-1206(10)62870-0. View

10.

Wang Z, Vilekar P, Huang J, Weaver D . Furosemide as a Probe Molecule for the Treatment of Neuroinflammation in Alzheimer's Disease. ACS Chem Neurosci. 2020; 11(24):4152-4168. DOI: 10.1021/acschemneuro.0c00445. View

11.

Tuttolomondo A, Di Raimondo D, Bellia C, Clemente G, Pecoraro R, Maida C . Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites. PLoS One. 2016; 11(12):e0165443. PMC: 5152809. DOI: 10.1371/journal.pone.0165443. View

12.

Williams G . Antitumor necrosis factor-alpha therapy and potential cancer inhibition. Eur J Cancer Prev. 2008; 17(2):169-77. DOI: 10.1097/CEJ.0b013e3282b6fcff. View

13.

Xu B, Makris A, Thornton C, Ogle R, Horvath J, Hennessy A . Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy. J Hypertens. 2006; 24(5):915-22. DOI: 10.1097/01.hjh.0000222762.84605.03. View

14.

Verma S, Singh A, Yadav G, Kushwaha R, Ali W, Verma S . Serum Tumor Necrosis Factor-Alpha Levels in Acute Leukemia and Its Prognostic Significance. Cureus. 2022; 14(5):e24835. PMC: 9090230. DOI: 10.7759/cureus.24835. View

15.

Xu B, Thornton C, Makris A, Ogle R, Hennessy A . Anti-hypertensive drugs alter cytokine production from preeclamptic placentas and peripheral blood mononuclear cells. Hypertens Pregnancy. 2007; 26(3):343-56. DOI: 10.1080/10641950701380958. View

16.

Wang Z, Wang Y, Vilekar P, Yang S, Gupta M, Oh M . Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide. PeerJ. 2020; 8:e9533. PMC: 7350920. DOI: 10.7717/peerj.9533. View

17.

Jang D, Lee A, Shin H, Song H, Park J, Kang T . The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. Int J Mol Sci. 2021; 22(5). PMC: 7962638. DOI: 10.3390/ijms22052719. View

18.

Hoang T, Levy B, Onetto N, Haman A . Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1989; 170(1):15-26. PMC: 2189388. DOI: 10.1084/jem.170.1.15. View

19.

Bryniarski P, Nazimek K, Marcinkiewicz J . Immunomodulatory Potential of Diuretics. Biology (Basel). 2021; 10(12). PMC: 8698805. DOI: 10.3390/biology10121315. View

20.

Binder S, Luciano M, Horejs-Hoeck J . The cytokine network in acute myeloid leukemia (AML): A focus on pro- and anti-inflammatory mediators. Cytokine Growth Factor Rev. 2018; 43:8-15. DOI: 10.1016/j.cytogfr.2018.08.004. View